How leaming Chinese becomes a new trend in Fiji
GUANGZHOU, China, Oct. 16, 2025 /PRNewswire/ -- News report from GDToday: In…
Excelrate Launches GEMS A First of its kind Growth Execution Management Software for Businesses
Excelrate today announced the launch of GEMS (Growth Execution Management Software), an…
IFQM Symposium 2025 to Drive India's Journey Towards Global Quality Leadership
The Indian Foundation for Quality Management (IFQM), established by a consortium of…
AM Best to Host Market Briefing at 2025 Singapore International Reinsurance Conference
SINGAPORE--(BUSINESS WIRE)--#insurance--AM Best’s Insurance Market Briefing - Singapore International Reinsurance Conference (SIRC)…
Taiho Pharmaceutical Exercises Option for an Exclusive License to Casdatifan in Japan and Certain Territories in Asia
TOKYO & HAYWARD, Calif.--(BUSINESS WIRE)--Taiho Pharmaceutical Co., Ltd. (“Taiho”) and Arcus Biosciences,…
Wialon Announces Top 10 GPS Hardware Manufacturers for 2025
DUBAI, UAE, Oct. 19, 2025 /PRNewswire/ -- Teltonika Telematics has once again been…
Manipal Hospital Sarjapur Road Empowers Fitness Enthusiasts with CPR Skills and First-Aid Workshop
BENGALURU, India, Oct. 14, 2025 /PRNewswire/ -- With the growing emphasis on…
Improving Public Health in the Global South by Leveraging Innovative Smoke-free Alternatives, focus at Technovation’25
NEW DELHI, Oct. 14, 2025 /PRNewswire/ --Â Philip Morris International (PMI) recently hosted…
Subcutaneous RYBREVANT(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer
Responses were rapid and durable, and tumour shrinkage was observed in 82…
PSMAddition data show Novartis Pluvicto delays progression to end-stage prostate cancer
Basel, October 19, 2025 – Novartis today presents new Pluvicto™ (lutetium (177Lu)…